Difference between revisions of "Neonatal hypoglycemia"

(Created page with "==Background== 3 births per 1000 w/ hypoglycemia Risks: DM mothers (hyperinsulin) Premies (can't store glycogen) Sick kids (depleted glycogen) Growth restricted babies (de...")
 
Line 1: Line 1:
 
==Background==
 
==Background==
 
 
 
3 births per 1000 w/ hypoglycemia
 
3 births per 1000 w/ hypoglycemia
  
Risks:
+
===Risks===
 
+
#DM mothers (hyperinsulin)
DM mothers (hyperinsulin)
+
#Premies (can't store glycogen)
 
+
#Sick kids (depleted glycogen)
Premies (can't store glycogen)
+
#Growth restricted babies (depleted glycogen)
 
+
#Macrosomic kids
Sick kids (depleted glycogen)
 
 
 
Growth restricted babies (depleted glycogen)
 
 
 
Macrosomic kids
 
 
 
 
  
 
==Diagnosis==
 
==Diagnosis==
 
 
 
blood glucose <40 mg/dL (preterm infants repeated levels below <50)
 
blood glucose <40 mg/dL (preterm infants repeated levels below <50)
  
+
===Signs & Sx===
 +
#Jitteriness and irritability
 +
#Apnea and cyanosis
 +
#Hypotonia
 +
#Convulsions
  
Signs & sx:
+
There is a normal fall in glucose @ 2-4hr
 
 
Jitteriness and irritability
 
 
 
Apnea and cyanosis
 
 
 
Hypotonia
 
 
 
Convulsions
 
 
 
 
 
 
 
 
 
There is nl. fall in glucose @ 2-4hr
 
 
 
 
  
 
==DDX==
 
==DDX==
 
+
# Decreased substrate availability
 
+
## Intra-uterine growth retardation
1. Decreased substrate availability:
+
## Glycogen storage disease
 
+
## Inborn errors (e.g., fructose intolerance)
* Intra-uterine growth retardation
+
## Prematurity
* Glycogen storage disease
+
## Prolonged fasting without IV glucose
* Inborn errors (e.g., fructose intolerance)
+
# Hyperinsulinemia:
* Prematurity
+
## Infant of diabetic mother
* Prolonged fasting without IV glucose
+
## Islet cell hyperplasia
2. Hyperinsulinemia:
+
## Erythroblastosis fetalis
 
+
## Exchange transfusion
* Infant of diabetic mother
+
## Beckwith-Wiedemann Syndrome
* Islet cell hyperplasia
+
## Maternal �-mimetic tocolytic agents
* Erythroblastosis fetalis
+
## ?High? umbilical arterial catheter
* Exchange transfusion
+
## Abrupt cessation of IV glucose
* Beckwith-Wiedemann Syndrome
+
# Other endocrine abnormalities:
* Maternal �-mimetic tocolytic agents
+
## Pan-hypopituitarism
* ?High? umbilical arterial catheter
+
## Hypothyroidism
* Abrupt cessation of IV glucose
+
## Adrenal insufficiency
3. Other endocrine abnormalities:
+
# Increased glucose utilization:
 
+
## Cold stress
* Pan-hypopituitarism
+
## Increased work of breathing
* Hypothyroidism
+
## Sepsis
* Adrenal insufficiency
+
## Perinatal asphyxia
4. Increased glucose utilization:
+
# Miscellaneous conditions:
 
+
## Polycythemia
* Cold stress
+
## Congenital heart disease
* Increased work of breathing
+
## CNS abnormalities
* Sepsis
 
* Perinatal asphyxia
 
5. Miscellaneous conditions:
 
 
 
* Polycythemia
 
* Congenital heart disease
 
* CNS abnormalities
 
 
   
 
   
 
+
===Ddx Persistent===
Ddx persistent:
+
#Too much insulin:
 
+
##idiopathic, asphyxia, rhesus dx, Beckwith-Weiderman, Nesiodoblastosis (autosomal recessive hyperinsulinism)
Too much insulin:
+
#Not enough anti-insulin:
 
+
##hypopit, adrenal hyperplasia
-idiopathic, asphyxia, rhesus dx, Beckwith-Weiderman, Nesiodoblastosis (autosomal recessive hyperinsulinism)
 
 
 
 
 
 
Not enough anti-insulin:
 
 
 
-hypopit, adrenal hyperplasia
 
  
 
   
 
   

Revision as of 19:44, 7 June 2011

Background

3 births per 1000 w/ hypoglycemia

Risks

  1. DM mothers (hyperinsulin)
  2. Premies (can't store glycogen)
  3. Sick kids (depleted glycogen)
  4. Growth restricted babies (depleted glycogen)
  5. Macrosomic kids

Diagnosis

blood glucose <40 mg/dL (preterm infants repeated levels below <50)

Signs & Sx

  1. Jitteriness and irritability
  2. Apnea and cyanosis
  3. Hypotonia
  4. Convulsions

There is a normal fall in glucose @ 2-4hr

DDX

  1. Decreased substrate availability
    1. Intra-uterine growth retardation
    2. Glycogen storage disease
    3. Inborn errors (e.g., fructose intolerance)
    4. Prematurity
    5. Prolonged fasting without IV glucose
  2. Hyperinsulinemia:
    1. Infant of diabetic mother
    2. Islet cell hyperplasia
    3. Erythroblastosis fetalis
    4. Exchange transfusion
    5. Beckwith-Wiedemann Syndrome
    6. Maternal �-mimetic tocolytic agents
    7.  ?High? umbilical arterial catheter
    8. Abrupt cessation of IV glucose
  3. Other endocrine abnormalities:
    1. Pan-hypopituitarism
    2. Hypothyroidism
    3. Adrenal insufficiency
  4. Increased glucose utilization:
    1. Cold stress
    2. Increased work of breathing
    3. Sepsis
    4. Perinatal asphyxia
  5. Miscellaneous conditions:
    1. Polycythemia
    2. Congenital heart disease
    3. CNS abnormalities

Ddx Persistent

  1. Too much insulin:
    1. idiopathic, asphyxia, rhesus dx, Beckwith-Weiderman, Nesiodoblastosis (autosomal recessive hyperinsulinism)
  2. Not enough anti-insulin:
    1. hypopit, adrenal hyperplasia


Inborn errors of metabolism:

-glycogen storage dz, fatty oxidation errors


Treatment

1) Glucometer reading 20-40 mg/dL, infant is term and is able to feed:

-Draw blood for stat blood glucose.

-Feed 5 mL/kg of D5W.

-Repeat blood glucose or Glucometer 20 min after feeding.


2) Glucometer reading:

    (a) <20 mg/dL or
    (b) <40 mg/dL and NPO or preterm or
    (c) <40 mg/dL after feeding or
    (d) <40 mg/dL and symptomatic

-Draw blood for stat glucose measurement.

-Give IV bolus of 2-3 mL/kg of D10W.

-Begin continuous infusion of D10W at 4-6 mg/kg/min.

-If infant of diabetic mother, begin D10W at 8-10 mg/kg/min (100-125 cc/kg/d).

-Repeat blood glucose in 20 min and pursue treatment until blood sugar >40 mg/dL.


3) For persistent hypoglycemia despite above measures:

-Increase rate of glucose infusion stepwise in 2 mg/kg/min* increments up to 12-15

mg/kg/min glucose. Use increased volume with caution in infants where volume

overload is a concern. Maximal concentration of glucose in peripheral IV is D12.5.

-If infant requires IV dextrose concentrations >12.5%, insert central venous catheter.


  • Do not use D25W or D50W IV or large IV volume boluses as this creates rebound

hypoglycemia in infants who are hyperinsulinemic. In addition, administration of D25W or

D50W can cause dangerous increase in plasma osmolarity.


4) If hypoglycemia is not controlled with above measures: Obtain Endocrine Consult to guide

further diagnostic evaluation and management. While awaiting consult, send blood (while blood

sugar is low) for glucose, plasma cortisol, growth hormone and insulin concentrations. Further

management may include glucocorticoids, diazoxide, somatostatin or pancreatectomy.


5) Weaning IV dextrose infusion: When blood glucose has been stable for 12-24 h, begin

decreasing IV infusion by 1-2 mL/hr q3-4 hours if blood glucose remains �60 mg/dL.

  • To calculate rate of glucose administration, use either of the following formulas:

(% glucose x mL/kg/d)/144 = glucose infusion rate (mg/kg/min)

or

(% glucose x mL/h)/(6 x body weight in kg) = glucose infusion rate (mg/kg/min)


Mgmt:

31-44: PO feed, check in 1 & 2 hr

31-44 x 2: D10W 2cc/kg bolus

> 45 PO feed @ 1st and 3rd hr


Mgmt of persistent hypoglycemia:

-Check insulin, GH, cortisol

-Increase volume by 30cc/kg/d

-Increase glucose to 12.5%

-Glucagon infusion


If continues for >7 d: send insulin, cortisol, growth hormone


Source

Adapted from Pani